Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Stringer

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.
Arthritis Care & Research|October 16, 2018
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes CohortJennifer J Y Lee, Ciarán M Duffy, Jaime Guzman, et al.
Arthritis Care & Research|November 15, 2011
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conferenceAdam M Huber, Angela B Robinson, Ann M Reed, et al.
The Journal of Rheumatology|February 2, 2022
Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology AssociationClaire E H Barber, Deborah M Levy, Vandana Ahluwalia, et al.
The Lancet. Global Health|June 14, 2024
Neurodevelopment in preschool children exposed and unexposed to Zika virus in utero in Nicaragua: a prospective cohort studyRyan Max, Christian Toval-Ruiz, Sylvia Becker-Dreps, et al.
The New England Journal of Medicine|October 15, 2010
Antiretroviral therapies in women after single-dose nevirapine exposureShahin Lockman, Michael D Hughes, James McIntyre, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
The Journal of Rheumatology|August 4, 2012
Access to biologic therapies in Canada for children with juvenile idiopathic arthritisClaire M A Leblanc, Bianca Lang, Alma Bencivenga, et al.
The Journal of Rheumatology|October 16, 2020
Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic ArthritisElham Rezaei, Marianna M Newkirk, Zhenhong Li, et al.
Rheumatology (Oxford, England)|April 23, 2020
Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categoriesElham Rezaei, Daniel Hogan, Brett Trost, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.
Arthritis Care & Research|October 16, 2018
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes CohortJennifer J Y Lee, Ciarán M Duffy, Jaime Guzman, et al.
Arthritis Care & Research|November 15, 2011
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conferenceAdam M Huber, Angela B Robinson, Ann M Reed, et al.
The Journal of Rheumatology|February 2, 2022
Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology AssociationClaire E H Barber, Deborah M Levy, Vandana Ahluwalia, et al.
The Lancet. Global Health|June 14, 2024
Neurodevelopment in preschool children exposed and unexposed to Zika virus in utero in Nicaragua: a prospective cohort studyRyan Max, Christian Toval-Ruiz, Sylvia Becker-Dreps, et al.
The New England Journal of Medicine|October 15, 2010
Antiretroviral therapies in women after single-dose nevirapine exposureShahin Lockman, Michael D Hughes, James McIntyre, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
The Journal of Rheumatology|August 4, 2012
Access to biologic therapies in Canada for children with juvenile idiopathic arthritisClaire M A Leblanc, Bianca Lang, Alma Bencivenga, et al.
The Journal of Rheumatology|October 16, 2020
Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic ArthritisElham Rezaei, Marianna M Newkirk, Zhenhong Li, et al.
Rheumatology (Oxford, England)|April 23, 2020
Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categoriesElham Rezaei, Daniel Hogan, Brett Trost, et al.
Pageof 8